Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2009 Financial Results
ImmunoGen, Inc., 08/07/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics using its antibody expertise and Targeted Antibody Payload technology, announced financial results for the fiscal year and three–month period ended June 2009.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09
Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09
Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09
Article Search
Sponsor